Immunosuppressive effects of danazol in vitro

J A Hill, Joseph A. Hill, R L Barbieri, Robert L. Barbieri, Deborah J. Anderson, D J Anderson
Fertility and Sterility · 1987 · vol. 48(3) , pp. 414–418 · doi:10.1016/s0015-0282(16)59408-4 · PMID:3622794 · W191974625
article OA: closed CC0 ⤵ 48 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Danazol was observed to suppress T-cell proliferation and IL-2 production in vitro.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Danazol Immunosuppression Therapy Pregnadienes Analysis of Variance Cell Division Cell Division Culture Media Danazol Dose-Response Relationship, Drug Estradiol Estradiol Female Hydrocortisone Hydrocortisone In Vitro Techniques Lymphocyte Activation Lymphocyte Activation Male Monocytes Monocytes

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Cited by (48)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:25.758913+00:00
License: CC0 · commercial use OK